Asia Pacific Leukapheresis Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product Type (Leukapheresis Devices and Leukapheresis Disposables), Application (Research Applications and Therapeutic Applications), and End User (Blood Component Providers and Blood Centers, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, and Hospitals and Transfusion Centers)
Market Introduction
The Asia Pacific Leukapheresis market is analyzed based on three large countries: the China, Japan, India, South Korea, Australia, and Rest of APAC. China is contributing a major share in the growth of leukapheresis market. Due to the rapid socio-economic development, environmental problems, lifestyle changes, and urbanization, China faces several obstacles in maintaining and improving people's health. The Chinese government announced the Healthy China 2030 Plan, emphasizing the strategic importance of health for China's growth. In 2018 there were approximately 506,003 public primary care facilities and around 437,636 private village clinics. In 2018 there were about 12,000 public hospitals and 21,000 private hospitals (excluding city and community hospitals), of which about 20,500 were non-profit, and 12,600 were for-profit. With increasing investments in the health sector and a rising leukemia rate, China is deriving the demand for the leukapheresis market. Patients with leukemia often present with severe anemia and thrombocytopenia. The leukapheresis machines currently used in clinical practice can cause rapid red blood cell and platelet loss, increasing the risk of bleeding, exacerbating anemia, and reducing the effectiveness of subsequent chemotherapy. Since the current method of leukocyte depletion requires increased systemic blood circulation and takes longer, it is difficult for some patients to tolerate it. Further improvements in leukapheresis machines to achieve rapid and accurate sorting of leukocytes and minimize the possible side effects during the procedure are the problems that urgently need to be resolved. The rising medical infrastructure, new technologies, studies, and investments owing to the increasing geriatric population as well as the cases of leukemia are paving the way for market growth. According to Globocan, an increase of over 14,000 cases of acute lymphoblastic leukemia is expected in China by 2029.
Countries in the Asia Pacific are facing challenges due to increasing incidences of COVID-19. The COVID-19 pandemic has put a major strain on the health systems of many countries around the world. The cases of COVID-19 in India, the pandemic caused by SARS-CoV-2, has reached to 10,582,647 and total deaths above 152,000 on January 19, 2021. There is currently no proven specific therapy, and multiple novel and repurposed molecules are being used on an experimental basis. The lack of effective therapeutic options has been a major hurdle in our pandemic mitigation measures. There are a few contender medicines including the malaria drug hydroxychloroquine, an antiviral Remdesivir, and Ivermectin, a drug used for worms and other parasites, but the results are not hugely encouraging and at times conflicting. In this backdrop, plasma therapy is being seen with interest as a cure for COVID-19 patients in India. Further, Medical equipment that carries out the apheresis procedure was installed at the GMCH at nearby Thrissur last month and the technique was used for the first time in Kerala to administer plasma to a 51-year old man. The apheresis procedure was carried out by GMC's technologists working with the departments of medicine, transfusion medicine and anesthesia.
Get more information on this report :
Market Overview and Dynamics
The leukapheresis market in Asia Pacific is expected to grow from US$ 14.69 million in 2021 to US$ 27.91 million by 2028; it is estimated to grow at a CAGR of 9.6% from 2021 to 2028. Blood transfusion is an integral part of the national health infrastructure and policies of various countries. Advancements in the medical industry have led to improvements in the treatment procedures of serious illnesses and injuries, which eventually has propelled the need for blood transfusion for patients’ survival. Growing awareness regarding the importance of blood transfusion and blood availability in healthcare services has led to rise in the number of people willing to donate their blood for medical causes. As per the World Health Organization (WHO) data, ~117.4 million blood donations were reported worldwide in 2018. Blood donors are usually classified to be voluntary unpaid, paid, and family/replacement, and as per the WHO claims, voluntary/unpaid donors are the major source of a reliable and adequate supply of blood. According to WHO data in 2019, blood donations by voluntary unpaid donors increased by 11.6 million from 2008 to 2015 in 139 countries in the world. The trend of blood donation is also gaining significant prominence in low and middle-income countries. According to the data presented during the CAG annual meeting 2017, ~13,000 procedures were performed on 1,087 patients in 2016. National programs developed and rolled out in many countries are further attracting a large number of platelet and blood donors. For example, in India, the National Blood Transfusion Council (NBTC), constituted within the National AIDS Control Organization (NACO), is the central body that coordinates with the State Blood Transfusion Councils (SBTCs), established within State AIDS Control Societies (SACS). The NBTC supports health programs for various activities related to blood transfusion services (BTS). Thus, the rising number of eligible donors in different countries across the world is fostering the need for leukapheresis equipment that is used to separate the required blood components.
Key Market Segments
In terms of product type, the leukapheresis disposables segment held a larger share in 2021. Based on application, research applications segment held the largest share in 2021. Based on end user, blood component providers and blood centers segment held the largest share in 2021.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the leukapheresis market in Asia Pacific are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Asahi Kasei Corporation; Fresenius SE & Co. KGaA; Haemonetics Corporation; Terumo Corporation; STEMCELL Technologies Inc.; HemaCare; Macopharma; AllCells; STEMEXPRESS; and BioIVT among others.
Reasons to buy report
- To understand the Asia Pacific leukapheresis market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for Asia Pacific leukapheresis market
- Efficiently plan M&A and partnership deals in Asia Pacific leukapheresis market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Asia Pacific leukapheresis market
- Obtain market revenue forecast for market by various segments from 2021-2028 in Asia Pacific region.
Asia Pacific Leukapheresis Market Segmentation
Asia Pacific Leukapheresis Market – By Product Type
- Leukapheresis Disposables
- Leukapheresis Devices
Asia Pacific Leukapheresis Market – By Application
- Research Applications
- Therapeutic Applications
Asia Pacific Leukapheresis Market – By Product Type
- Blood Component Providers and Blood Centers
- Hospitals and Transfusion Centers
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
Asia Pacific Leukapheresis Market – By Country
- China
- Japan
- India
- South Korea
- Australia
- Rest of APAC
Asia Pacific Leukapheresis Market – Companies Mentioned
- Asahi Kasei Corporation
- Fresenius SE & Co. KGaA
- Haemonetics Corporation
- Terumo Corporation
- STEMCELL Technologies Inc.
- HemaCare
- Macopharma
- AllCells
- STEMEXPRESS
- BioIVT
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Leukapheresis Market – By Product Type
1.3.2 Asia Pacific Leukapheresis Market – By Application
1.3.3 Asia Pacific Leukapheresis Market – By End User
1.3.4 Asia Pacific Leukapheresis Market – By Country
2. Asia Pacific Leukapheresis Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Leukapheresis – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Expert Opinions
5. Asia Pacific Leukapheresis Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Expanding Number of Voluntary Blood Donors
5.1.2 Up-Scaling Incidence of Hematologic Diseases
5.1.3 Growing Elderly Population
5.2 Key Market Restraints
5.2.1 Expensive Cost of Leukapheresis
5.3 Key Market Opportunities
5.3.1 Heighten opportunities in Emerging Economies
5.4 Future Trends
5.4.1 Expansion in Therapeutic Apheresis
5.5 Impact Analysis
6. Asia Pacific Leukapheresis – Market Analysis
6.1 Asia Pacific Leukapheresis Market Revenue Forecast and Analysis
7. Asia Pacific Leukapheresis Market Analysis – by Product Type
7.1 Overview
7.2 Asia Pacific Leukapheresis Market Share by Product Type 2021 & 2028 (%)
7.3 Leukapheresis Devices
7.3.1 Overview
7.3.2 Leukapheresis Devices Market Revenue and Forecast to 2028 (US$ Million)
7.3.2.1 Apheresis Devices
7.3.2.1.1 Overview
7.3.2.1.2 Apheresis Devices Market Revenue and Forecast to 2028 (US$ Million)
7.3.2.2 Leukapheresis ColuMillions and Cell Separators
7.3.2.2.1 Overview
7.3.2.2.2 Leukapheresis ColuMillions and Cell Separators Market Revenue and Forecast to 2028 (US$ Million)
7.3.2.3 Leukoreduction Filters
7.3.2.3.1 Overview
7.3.2.3.2 Leukoreduction Filters Market Revenue and Forecast to 2028 (US$ Million)
7.4 Leukapheresis Disposables
7.4.1 Overview
7.4.2 Leukapheresis Disposables Market Revenue and Forecast to 2028 (US$ Million)
8. Asia Pacific Leukapheresis Market Analysis – by Application
8.1 Overview
8.2 Asia Pacific Leukapheresis Market Share by Application 2021 & 2028 (%)
8.3 Research Applications
8.3.1 Overview
8.3.2 Research Applications Market Revenue and Forecast to 2028 (US$ Million)
8.4 Therapeutic Applications
8.4.1 Overview
8.4.2 Therapeutic Applications Market Revenue and Forecast to 2028 (US$ Million)
9. Asia Pacific Leukapheresis Market Analysis – by End-User
9.1 Overview
9.2 Asia Pacific Leukapheresis Market Share by End-User 2021 & 2028 (%)
9.3 Pharmaceutical and Biotechnology Companies
9.3.1 Overview
9.3.2 Pharmaceutical and Biotechnology Companies Market Revenue and Forecast to 2028 (US$ Million)
9.4 Blood Component Providers and Blood Centers
9.4.1 Overview
9.4.2 Blood Component Providers and Blood Centers Market Revenue and Forecast to 2028 (US$ Million)
9.5 Academic and Research Institutes
9.5.1 Overview
9.5.2 Academic and Research Institutes Market Revenue and Forecast to 2028 (US$ Million)
9.6 Hospitals and Transfusion Centers
9.6.1 Overview
9.6.2 Hospitals and Transfusion Centers Market Revenue and Forecast to 2028 (US$ Million)
10. Asia Pacific Leukapheresis Market – Country Analysis
10.1 Overview
10.1.2 Asia Pacific: Leukapheresis Market, by Country, 2021 & 2028 (%)
10.1.2.1 China: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.1 Overview
10.1.2.1.2 China: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.3 China: Leukapheresis Market, By Product type, 2019–2028 (USD Million)
10.1.2.1.3.1 China: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)
10.1.2.1.4 China: Leukapheresis Market, by Application, 2019–2028 (USD Million)
10.1.2.1.5 China: Leukapheresis Market, by End User, 2019–2028 (USD Million)
10.1.2.2 Japan: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.1 Overview
10.1.2.2.2 Japan: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.3 Japan: Leukapheresis Market, By Product type, 2019–2028 (USD Million)
10.1.2.2.3.1 Japan: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)
10.1.2.2.4 Japan: Leukapheresis Market, by Application, 2019–2028 (USD Million)
10.1.2.2.5 Japan: Leukapheresis Market, by End User, 2019–2028 (USD Million)
10.1.2.3 India: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.1 Overview
10.1.2.3.2 India: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.3 India: Leukapheresis Market, By Product type, 2019–2028 (USD Million)
10.1.2.3.3.1 Canada: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)
10.1.2.3.4 India: Leukapheresis Market, by Application, 2019–2028 (USD Million)
10.1.2.3.5 India: Leukapheresis Market, by End User, 2019–2028 (USD Million)
10.1.2.4 Australia: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.4.1 Overview
10.1.2.4.2 Australia: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.4.3 Australia: Leukapheresis Market, By Product type, 2019–2028 (USD Million)
10.1.2.4.3.1 Australia: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)
10.1.2.4.4 Australia: Leukapheresis Market, by Application, 2019–2028 (USD Million)
10.1.2.4.5 Australia: Leukapheresis Market, by End User, 2019–2028 (USD Million)
10.1.2.5 South Korea: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.5.1 Overview
10.1.2.5.2 South Korea: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.5.3 South Korea: Leukapheresis Market, By Product type, 2019–2028 (USD Million)
10.1.2.5.3.1 South Korea: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)
10.1.2.5.4 South Korea: Leukapheresis Market, by Application, 2019–2028 (USD Million)
10.1.2.5.5 South Korea: Leukapheresis Market, by End User, 2019–2028 (USD Million)
10.1.2.6 Rest of Asia Pacific: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.6.1 Overview
10.1.2.6.2 Rest of Asia Pacific: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.6.3 Rest of Asia Pacific: Leukapheresis Market, By Product type, 2019–2028 (USD Million)
10.1.2.6.3.1 Rest of Asia Pacific: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)
10.1.2.6.4 Rest of Asia Pacific: Leukapheresis Market, by Application, 2019–2028 (USD Million)
10.1.2.6.5 Rest of Asia Pacific: Leukapheresis Market, by End User, 2019–2028 (USD Million)
11. Asia Pacific Leukapheresis Market – Impact of COVID-19 Pandemic
11.1 Impact Assessment of COVID-19 Pandemic
12. Asia Pacific Leukapheresis Market – Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 Asahi Kasei Corporation
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Fresenius SE & Co. KGaA
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Haemonetics Corporation
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Terumo Corporation
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 STEMCELL Technologies Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 HemaCare
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Macopharma
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 AllCells
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 STEMEXPRESS
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 BioIVT
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About the Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. China: Leukapheresis Market, By Product type – Revenue and Forecast to 2028 (USD Million)
Table 2. China Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)
Table 3. China Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 4. China: Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 5. Japan: Leukapheresis Market, By Product type– Revenue and Forecast to 2028 (USD Million)
Table 6. Japan Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)
Table 7. Japan Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 8. Japan: Leukapheresis Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 9. India: Leukapheresis Market, By Product type– Revenue and Forecast to 2028 (USD Million)
Table 10. India Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)
Table 11. India Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 12. India: Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 13. Australia: Leukapheresis Market, By Product type – Revenue and Forecast to 2028 (USD Million)
Table 14. Australia Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)
Table 15. Australia Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 16. Australia: Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 17. South Korea: Leukapheresis Market, By Product type – Revenue and Forecast to 2028 (USD Million)
Table 18. South Korea Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)
Table 19. South Korea Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 20. South Korea: Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 21. Rest of Asia Pacific: Leukapheresis Market, By Product type – Revenue and Forecast to 2028 (USD Million)
Table 22. Rest of Asia Pacific Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)
Table 23. Rest of Asia Pacific Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 24. Rest of Asia Pacific: Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 25. Organic Developments Done by Companies
Table 26. Inorganic Developments Done by Companies
Table 27. Glossary of Terms, Leukapheresis Market
LIST OF FIGURES
Figure 1. Asia Pacific Leukapheresis Market Segmentation
Figure 2. Asia Pacific Leukapheresis Market Segmentation, By country
Figure 3. Asia Pacific Leukapheresis Market Overview
Figure 4. Leukapheresis Disposables Segment Held Largest Share of Leukapheresis Market
Figure 5. China to Show Significant Growth During Forecast Period
Figure 6. Asia Pacific Leukapheresis Market, Industry Landscape
Figure 7. Asia Pacific PEST Analysis
Figure 8. Asia Pacific Leukapheresis market impact analysis of driver and restraints
Figure 9. Asia Pacific Leukapheresis Market – Revenue Forecast and Analysis to 2021-2028
Figure 10. Asia Pacific Leukapheresis Market Share by Product Type 2021 & 2028 (%)
Figure 11. Leukapheresis Devices Market Revenue and Forecasts to 2028 (US$ Million)
Figure 13. Apheresis Devices Market Revenue and Forecasts to 2028 (US$ Million)
Figure 14. Leukapheresis ColuMillions and Cell Separators Market Revenue and Forecasts to 2028 (US$ Million)
Figure 15. Leukoreduction Filters Market Revenue and Forecasts to 2028 (US$ Million)
Figure 16. Leukapheresis Disposables Market Revenue and Forecasts to 2028 (US$ Million)
Figure 17. Asia Pacific Leukapheresis Market Share by Application 2021 & 2028 (%)
Figure 18. Research Applications Market Revenue and Forecasts to 2028 (US$ Million)
Figure 19. Therapeutic Applications Market Revenue and Forecasts to 2028 (US$ Million)
Figure 20. Asia Pacific Leukapheresis Market Share by End-User 2021 & 2028 (%)
Figure 21. Pharmaceutical and Biotechnology Companies Market Revenue and Forecasts to 2028 (US$ Million)
Figure 22. Blood Component Providers and Blood Centers Market Revenue and Forecasts to 2028 (US$ Million)
Figure 23. Academic and Research Institutes Market Revenue and Forecasts to 2028 (US$ Million)
Figure 24. Hospitals and Transfusion Centers Market Revenue and Forecasts to 2028 (US$ Million)
Figure 25. Asia Pacific: Leukapheresis Market, by Key Country – Revenue (2021) (USD Million)
Figure 26. Asia Pacific: Leukapheresis Market, by Country, 2021 & 2028 (%)
Figure 27. China: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
Figure 28. Japan: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
Figure 29. India: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
Figure 30. Australia: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
Figure 31. South Korea: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
Figure 32. Rest of Asia Pacific: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
Figure 33. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
- Asahi Kasei Corporation
- Fresenius SE & Co. KGaA
- Haemonetics Corporation
- Terumo Corporation
- STEMCELL Technologies Inc.
- HemaCare
- Macopharma
- AllCells
- STEMEXPRESS
- BioIVT
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific leukapheresis market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific leukapheresis market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the leukapheresis market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution